Skip to content
naulon
Not checkedNot checked for notices yet.

Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by Gram-positive and Gram-negative bacteria in human airway smooth muscle cells

Chung Kian Fan, Sriskandan Shiranee, Sukkar Maria B and 3 more

Respiratory Research · 2008

doi:10.1186/1465-9921-9-30 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Bacterial infections are a cause of exacerbation of airway disease. Airway smooth muscle cells (ASMC) are a source of inflammatory cytokines/chemokines that may propagate local airway inflammatory responses. We hypothesize that bacteria and bacterial products could induce cytokine/chemokine release from ASMC.</p> <p>Methods</p> <p>Human ASMC were grown in culture and treated with whole bacteria or pathogen associated molecular patterns (PAMPs) for 24 or 48 h. The release of eotaxin-1, CXCL-8 or GMCSF was measured by ELISA.</p> <p>Results</p> <p>Gram-negative <it>E. coli </it>or Gram-positive <it>S. aureus </it>increased the release of CXCL-8, as did IL-1β, LPS, FSL-1 and Pam<sub>3</sub>CSK4, whereas FK565, MODLys18 or Poly I:C did not. <it>E. coli </it>inhibited eotaxin-1 release under control conditions and after stimulation with IL-1β. <it>S. aureus </it>tended to inhibit eotaxin-1 release stimulated with IL-1β. <it>E. coli </it>or LPS, but not <it>S. aureus</it>, induced the release of GMCSF.</p> <p>Conclusion</p> <p>Gram-positive or Gram-negative bacteria activate human ASMC to release CXCL-8. By contrast Gram-negative bacteria inhibited the release of eotaxin-1 from human ASMCs. <it>E. coli</it>, but not <it>S. aureus </it>induced GMCSF release from cells.</p> <p>Our findings that ASMC can respond directly to Gram-negative and Gram-positive bacteria by releasing the neutrophil selective chemokine, CXCL-8, is consistent with what we know about the role of neutrophil recruitment in bacterial infections in the lung. Our findings that bacteria inhibit the release of the eosinophil selective chemokine, eotaxin-1 may help to explain the mechanisms by which bacterial immunotherapy reduces allergic inflammation in the lung.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.